Business Context and Reporting Period
Company: The Cooper Companies, Inc.
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended January 31, 1999
Business Overview: The Company develops, manufactures, and markets healthcare products through two primary segments: CooperVision (CVI), specializing in contact lenses including toric lenses for astigmatism, and CooperSurgical (CSI), providing diagnostic products and surgical instruments for women's healthcare.
Key Financial Metrics
| Metric (in thousands) | Q1 1999 | Q1 1998 |
|---|---|---|
| Net Sales | $34,959 | $29,384 |
| Gross Profit | $21,543 | $18,107 |
| Gross Margin | 62% | 62% |
| Operating Income (Continuing) | $5,903 | $5,219 |
| Net Income | $3,899 | $5,993 |
| Diluted EPS | $0.27 | $0.39 |
| Cash and Equivalents (End of Period) | $5,774 | $8,757 |
| Total Debt (Current + Long-term) | $80,930 | $85,635 |
| Operating Cash Flow | $(3,430) | $(7,035) |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated revenue increased 19% to $35.0 million, driven by a 21% increase at CVI (partially due to the full quarter impact of the Aspect Vision Care acquisition) and a 10% increase at CSI.
- Profitability: While operating income from continuing operations rose 13%, Net Income declined 35% to $3.9 million. This decline is primarily attributed to a $4.7 million decrease in income from discontinued operations (HGA) and a shift from a tax benefit in 1998 to a tax provision in 1999.
- Discontinued Operations: The Company recorded a $1.3 million gain on the disposal of a portion of its Hospital Group of America (HGA) business in Q1 1999, compared to $650,000 net income from HGA in Q1 1998.
- Interest Expense: Increased 67% to $1.8 million, reflecting debt incurred for the Aspect acquisition and the stock repurchase program.
- Share Repurchases: The Company completed the repurchase of 1 million shares of common stock authorized in September 1998, with 125,000 shares purchased in Q1 1999.
Guidance, Outlook, and Risks
- HGA Disposition: Management expects to close the sale of the remainder of HGA to Universal Health Services, Inc. by the end of the second fiscal quarter for approximately $27 million plus potential contingent payments. Proceeds may be used for debt repayment or further share repurchases.
- Tax Outlook: The effective tax rate for Q1 1999 was approximately 35%. Management anticipates reducing the effective rate to approximately 30% over the next several years through a global tax plan utilizing net operating loss carryforwards.
- Year 2000 (Y2K): The Company is implementing a Y2K compliance program expected to be substantially completed by mid-1999. Estimated total costs are $500,000, with $200,000 already expended. Contingency plans are in place for potential disruptions.
- Environmental Contingency: An environmental remediation project at a CVI site involving groundwater contamination is underway. The Company has accrued approximately $500,000 and does not expect costs to be material beyond this amount.
- Liquidity: Cash flow from continuing operations is expected to fund ongoing operations. The Company had $5.6 million available under its KeyBank line of credit as of January 31, 1999.
Investor Verification Checklist
- HGA Sale Closing: Verify the timing and final proceeds of the remaining HGA sale to Universal Health Services, as this impacts cash flow and debt reduction plans.
- Aspect Integration: Monitor CVI's ability to sustain margin improvements and revenue growth following the integration of Aspect Vision Care.
- Debt Servicing: Review the impact of increased interest expense on future operating income, particularly as the Company carries significant debt from acquisitions.
- Y2K Compliance: Confirm the successful completion of Y2K remediation for internal systems and critical third-party vendors to avoid operational disruptions.
- Tax Strategy Execution: Track the realization of the projected 30% effective tax rate and the utilization of net operating loss carryforwards.